381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more
In this episode, Peter Attia interviews neuroscientist Lisa Mosconi about why Alzheimer's disease disproportionately affects women at roughly a 2-to-1 ratio compared to men—a disparity that cannot be explained by longevity alone. Mosconi presents evidence that women begin developing Alzheimer's pathology in midlife, particularly during the menopausal transition when estrogen levels decline sharply, and discusses how menopausal hormone therapy initiated at the right time may help reduce cognitive decline and dementia risk. The conversation covers cutting-edge brain imaging techniques, estrogen receptor biology, and Mosconi's ambitious $50 million CARE research initiative aimed at preventing Alzheimer's in women globally.
Key takeaways
- • Women show higher brain pathology burden in midlife compared to age-matched men with the same genetic risk factors, suggesting Alzheimer's disease begins decades before symptoms appear.
- • The APOE4 gene confers a 4-6 fold increased dementia risk in women versus a 2-fold increase in men, demonstrating that sex-specific genetic risk models are critical for Alzheimer's prevention.
- • Estrogen receptor density in the pituitary gland actually increases after menopause, contradicting rodent models and suggesting the "window of opportunity" for hormone therapy may extend beyond age 65.
- • Early initiation of menopausal hormone therapy (within 10 years of final menstrual period) is associated with a 23-32% reduced dementia risk in observational studies, particularly with estrogen-only therapy in hysterectomized women.
- • The blood-brain barrier actively regulates estrogen transport, meaning peripheral estrogen levels tell you almost nothing about estrogen availability in the brain or symptom severity during menopause.
- • Advanced MRI techniques including DTI, ASL, and phosphorus spectroscopy can now measure brain white matter integrity, blood flow, and neuronal energy production to identify Alzheimer's pathology years before cognitive decline.
Recommendations (7)
"There's a whole mathematical model that we're using. It's called the Logan plot."
Peter Attia · ▶ 41:10
"The way that this tracer works is called flurin 18 fluoroestradiol is that it goes up in the brain and it looks for the estrogen receptors."
Peter Attia · ▶ 37:37
"We do 31P phosphor phosphorus 31 magnetic resonance spectroscopy to look at ATP production in the brain."
Peter Attia · ▶ 32:18
Mentioned (8)
More from these creators
How Women Can Start Alzheimer’s Prevention | Lisa Mosconi, Ph.D.
Cooking with Lard vs Seed Oils | Layne Norton, Ph.D.
380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?
A guide to cardiorespiratory training at any fitness level to improve longevity (AMA 79 sneak peek)
378 ‒ Women’s health & performance: how training, nutrition, & hormones interact across life stages
How Your Environment Quietly Controls Your Habits | James Clear